Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SEATTLE, WA--(Marketwire - Oct 18, 2011) - ALLOZYNE, Inc. announced today positive initial results from its multiple ascending dose (MAD) phase IB trial for its lead product candidate, AZ01, a...
-
SOUTH SAN FRANCISCO, CA--(Marketwire - Oct 6, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to...
-
Threshold Pharmaceuticals Initiates Phase 3 TH-302 Combination Trial in Advanced Soft Tissue Sarcoma
REDWOOD CITY, CA--(Marketwire - Sep 30, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Threshold, in collaboration with Sarcoma Alliance for Research through...
-
SOUTH SAN FRANCISCO, CA--(Marketwire - Sep 22, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to...
-
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN--(Marketwire - Sep 19, 2011) - Sunshine Heart, Inc. (ASX: SHC), today announced it closed its two-tranche financing on September 16, 2011, raising a total of...
-
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN--(Marketwire - Sep 16, 2011) - Sunshine Heart, Inc. (ASX: SHC) today announced that Jeff Mathiesen and Kevin Bassett, Sunshine's Chief Financial Officer and...
-
REDWOOD CITY, CA--(Marketwire - Sep 6, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at...
-
REDWOOD CITY, CA--(Marketwire - Sep 2, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at...
-
MELBOURNE, AUSTRALIA--(Marketwire - Aug 17, 2011) - Biota Holdings Limited (ASX: BTA) Highlights BARDA awarded a major contract to Biota for the advanced...
-
MELBOURNE, AUSTRALIA--(Marketwire - October 21, 2010) - Biota Holdings Limited (ASX: BTA) today advised that it had received written notification from GlaxoSmithKline (GSK) that, for the three...